Updates

Craneware - Two significant new contracts

March 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Craneware trades entirely in the US where it is the market leader in the supply of billing software analysis tools for the healthcare sector.Complicated regulatory changes lead to many errors in billing for medical services. Craneware's software solves these and other problems and the company has just reported two significant new contracts with hospital providers. One is worth US$5m and the other US$3.5m over their initial multi year terms.The shares went back to their highs on the news. Gain since main write up is 160%, keep holding. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Altitude

Growth Portfolio 3 - March '18

Craneware (September 2024)

Craneware - Growing pipeline of opportunities (October 2023)

Craneware (July 2019)

Craneware (August 2018)

Craneware - Gain since main profile: 154% (February 2018)

Craneware - Bullet proof business (October 2016)

Craneware (August 2016)

Craneware - Big beneficiary of Obamacare (November 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X